Nocturnal CPAP improves walking capacity in COPD patients with obstructive sleep apnoea

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Wang, Tsai Yu ^a   Lo, Yu Lun ^a   Lee, Kang Yun ^a   Liu, Wen Te ^b,c   Lin, Shu Min ^a   Lin, Ting Yu ^a   Ni, Yung Lun ^d   Wang, Chao Yung ^a   Ho, Shu Chuan ^a,c   Kuo, Han Pin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b Shuang Ho Hospital   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Autonomic dysfunction; Chronic obstructive pulmonary disease; Continuous positive airway pressure; Obstructive sleep apnoea; Walking capacity

Indexed keywords

CATECHOLAMINE;

AGED; APNEA HYPOPNEA INDEX; ARTICLE; AUTONOMIC DYSFUNCTION; CATECHOLAMINE URINE LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EXERCISE TEST; FEMALE; HEART RATE; HEART RATE VARIABILITY; HUMAN; MALE; OXYGEN DESATURATION; OXYGENATION; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP DISORDERED BREATHING; TREATMENT DURATION; WALKING; COMPLICATION; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SLEEP APNEA, OBSTRUCTIVE; URINE;

AGED; CATECHOLAMINES; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SLEEP APNEA, OBSTRUCTIVE; WALKING;

EID: 84879035780     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-66     Document Type: Article

References (36)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176(6):532-555. 10.1164/rccm.200703-456SO, 17507545.
2. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 171(9):972-977. 10.1164/rccm.200407-855OC, 15665324.
3. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006, 129(3):536-544. 10.1378/chest.129.3.536, 16537849.
4. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006, 119(10 Suppl 1):21-31.
5. Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Magnussen H. Physical activity is the strongest predictor of all-cause mortality in patients with chronic obstructive pulmonary disease: a prospective cohort study. Chest 2011, 140(2):331-342. 10.1378/chest.10-2521, 21273294.
6. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006, 61(9):772-778. 10.1136/thx.2006.060145, 2117100, 16738033.
7. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994, 7(4):725-729. 10.1183/09031936.94.07040725, 8005256.
8. Dam TT, Ewing S, Ancoli-Israel S, Ensrud K, Redline S, Stone K. Association between sleep and physical function in older men: the osteoporotic fractures in men sleep study. J Am Geriatr Soc 2008, 56(9):1665-1673. 10.1111/j.1532-5415.2008.01846.x, 2631084, 18759758.
9. Leggett RJ, Flenley DC. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale. Br Med J 1977, 2(6079):84-86. 10.1136/bmj.2.6079.84, 1630967, 871805.
10. Davidson AC, Leach R, George RJ, Geddes DM. Supplemental oxygen and exercise ability in chronic obstructive airways disease. Thorax 1988, 43(12):965-971. 10.1136/thx.43.12.965, 461601, 3238640.
11. Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Vessey RS, Wedzicha JA. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006, 174(8):867-874. 10.1164/rccm.200604-506OC, 16799074.
12. Kent BD, McNicholas WT, Verbraecken J. Disturbed sleep and COPD outcomes: cart meets horse. Sleep Med 2012, 13(5):453-454. 10.1016/j.sleep.2012.02.001, 22437143.
13. Marklund M, Verbraecken J, Randerath W. Non-CPAP therapies in obstructive sleep apnoea: mandibular advancement device therapy. Eur Respir J 2012, 39(5):1241-1247. 10.1183/09031936.00144711, 22075487.
14. Basner RC. Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med 2007, 356(17):1751-1758. 10.1056/NEJMct066953, 17460229.
15. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008, 4(2):157-171. 2335396, 18468315.
16. EEG arousals Scoring rules and examples: a preliminary report from the sleep disorders atlas task force of the american sleep disorders association. Sleep 1992, 15(2):173-184. EEG arousals.
17. Sleep-related breathing disorders in adults Recommendations for syndrome definition and measurement techniques in clinical research. the report of an american academy of sleep medicine task force. Sleep 1999, 22(5):667-689. Sleep-related breathing disorders in adults.
18. Rosano TG, Swift TA, Hayes LW. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem 1991, 37(10 Pt 2):1854-1867.
19. Rosano TG. Liquid-chromatographic evaluation of age-related changes in the urinary excretion of free catecholamines in pediatric patients. Clin Chem 1984, 30(2):301-303.
20. Liu WT, Wang CH, Lin HC, Lin SM, Lee KY, Lo YL, Hung SH, Chang YM, Chung KF, Kuo HP. Efficacy of a cell phone-based exercise programme for COPD. Eur Respir J 2008, 32(3):651-659. 10.1183/09031936.00104407, 18508824.
21. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992, 47(12):1019-1024. 10.1136/thx.47.12.1019, 1021093, 1494764.
22. Weitzenblum E, Chaouat A, Kessler R, Canuet M, Hirschi S. The overlap syndrome: association of COPD and obstructive sleep apnoea. Rev Mal Respir 2010, 27(4):329-340. 10.1016/j.rmr.2010.03.002, 20403543.
23. Aihara K, Oga T, Harada Y, Chihara Y, Handa T, Tanizawa K, Watanabe K, Tsuboi T, Hitomi T, Mishima M, et al. Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med 2011, 105(6):939-945. 10.1016/j.rmed.2011.02.016, 21402472.
24. Singh SJ, Jones PW, Evans R, Morgan MD. Minimum clinically important improvement for the incremental shuttle walking test. Thorax 2008, 63(9):775-777. 10.1136/thx.2007.081208, 18390634.
25. Prohaska TR, Eisenstein AR, Satariano WA, Hunter R, Bayles CM, Kurtovich E, Kealey M, Ivey SL. Walking and the preservation of cognitive function in older populations. Gerontologist 2009, 49(Suppl 1):S86-93.
26. McGuire M, MacDermott M, Bradford A. Effects of chronic intermittent asphyxia on rat diaphragm and limb muscle contractility. Chest 2003, 123(3):875-881. 10.1378/chest.123.3.875, 12628891.
27. Chien MY, Wu YT, Lee PL, Chang YJ, Yang PC. Inspiratory muscle dysfunction in patients with severe obstructive sleep apnoea. Eur Respir J 2010, 35(2):373-380. 10.1183/09031936.00190208, 19643936.
28. Mougin F, Simon-Rigaud ML, Davenne D, Renaud A, Garnier A, Kantelip JP, Magnin P. Effects of sleep disturbances on subsequent physical performance. Eur J Appl Physiol Occup Physiol 1991, 63(2):77-82. 10.1007/BF00235173, 1748108.
29. Lin CC, Hsieh WY, Chou CS, Liaw SF. Cardiopulmonary exercise testing in obstructive sleep apnea syndrome. Respir Physiol Neurobiol 2006, 150(1):27-34. 10.1016/j.resp.2005.01.008, 16448931.
30. Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100(23):2332-2335. 10.1161/01.CIR.100.23.2332, 10587337.
31. Ketelaars CA, Schlösser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996, 51(1):39-43. 10.1136/thx.51.1.39, 472797, 8658367.
32. Middlekauff HR. Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure. Circ Heart Fail 2010, 3(4):537-546. 10.1161/CIRCHEARTFAILURE.109.903773, 3056569, 20647489.
33. Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010, 182(3):325-331. 10.1164/rccm.200912-1869OC, 20378728.
34. Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 2007, 132(6):1778-1785. 10.1378/chest.07-2050, 17925409.
35. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol 1982, 33(4):379-387. 10.1016/S0009-9260(82)80301-2, 7083738.
36. Heinzer RC, Stanchina ML, Malhotra A, Jordan AS, Patel SR, Lo YL, Wellman A, Schory K, Dover L, White DP. Effect of increased lung volume on sleep disordered breathing in patients with sleep apnoea. Thorax 2006, 61(5):435-439. 10.1136/thx.2005.052084, 2111199, 16490766.